Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > Anybody know when Q1 2021 will be out?
View:
Post by nocashnoluck on Apr 07, 2021 12:34pm

Anybody know when Q1 2021 will be out?

should be soon correct? thanks!
Comment by CGCFAN on Apr 07, 2021 6:40pm
I emailed investor relations in March they said "end of april"  and I received a reply the same day for what it's worth.  I think for KHRN to get some respect in the martkets we need some revs i think they are an absolute winner and a fantastic long term play, but a race to an ATH is light years away    prove me wrong KHRN !!  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities